- Report
- July 2026
- 180 Pages
Global
From €4387EUR$4,750USD£3,670GBP
- Report
- July 2026
- 110 Pages
Global
From €4387EUR$4,750USD£3,670GBP
- Report
- November 2025
- 160 Pages
Global
From €2919EUR$3,160USD£2,441GBP
€3648EUR$3,950USD£3,052GBP
- Report
- June 2025
- 83 Pages
United States
From €3233EUR$3,500USD£2,704GBP
- Report
- August 2025
- 150 Pages
Global
From €2919EUR$3,160USD£2,441GBP
€3648EUR$3,950USD£3,052GBP
Patient Blood Management (PBM) is a medical strategy that focuses on optimizing the care of patients who require blood transfusions. It is a multidisciplinary approach that involves the use of evidence-based practices to reduce the need for allogeneic blood transfusions, while ensuring the safety of the patient. PBM includes strategies such as preoperative anemia management, intraoperative blood salvage, and the use of alternative blood products. It also involves the use of blood conservation techniques such as cell salvage, erythropoietin, and iron supplementation.
PBM is an important part of blood banking, as it helps to reduce the demand for allogeneic blood transfusions and improve patient outcomes. It is also beneficial to blood banks, as it helps to reduce the cost of blood products and improve the efficiency of the blood supply.
Some companies in the PBM market include Fresenius Kabi, Haemonetics Corporation, Terumo BCT, and Grifols. Show Less Read more